fbpx

Researchers find drug used widely to treat eye condition has 'no benefit'

Researchers from the University of Bristol and University Hospital Southampton have found that a drug used widely to treat a common eye condition has “no benefit” and should no longer be used.
Eplerenone, which is primarily used to treat heart failure, is currently offered widely by ophthalmologists as a treatment for central serous chorioretinopathy (CSCR) based on limited clinical data.